Old Web
English
Sign In
Acemap
>
authorDetail
>
Erik Bloomquist
Erik Bloomquist
Silver Spring Networks
Pathology
Medicine
Cancer
Breast cancer
Aromatase inhibitor
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Benefit of CDK 4/6 inhibition in less common breast cancer subsets: A U.S. Food and Drug Administration pooled analysis.
2018
Journal of Clinical Oncology
Jennifer J Gao
Joyce Cheng
Erik Bloomquist
Robert Schroeder
Laleh Amiri-Kordestani
Rajeshwari Sridhara
Gideon M. Blumenthal
Richard Pazdur
Julia A. Beaver
Tatiana Prowell
Show All
Source
Cite
Save
Citations (8)
A U.S. Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC).
2016
Journal of Clinical Oncology
S Wedam
Julia A. Beaver
Laleh Amiri-Kordestani
Erik Bloomquist
Shenghui Tang
Rajeshwari Sridhara
Amna Ibrahim
Geoffrey Kim
Paul G. Kluetz
Amy E. McKee
Richard Pazdur
Show All
Source
Cite
Save
Citations (0)
1